Richard A. Paulson, President and CEO: Karyopharm Therapeutics KPTI Sell · Filed 03/03

Trade details

Type: Insider sale
Amount: $116,317.01
Shares · price: 12,361 sh · $9.41 a share
Held after: 267,030 sh
Stock: Karyopharm Therapeutics KPTI
Person: Richard A. PaulsonPresident and CEO
Trade date: 26/03/02
Filed: 26/03/03
Days to filing: 1 days

Sold 4.4% of holdings

Share of holding sold: 4.4%

Karyopharm Therapeutics trades, last 26 weeks

What else happened in Karyopharm Therapeutics around then

Filed or reported within 30 days of the trade day · 01/31~04/01

Richard A. Paulson's recent trades

Richard A. PaulsonPresident and CEO
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$20.9K
2,203 sh
$20.9K
Filed 05/15
Traded 05/14
Richard A. PaulsonPresident and CEO
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$8,083
1,257 sh
$8,083
Filed 25/09/16
Traded 25/09/15
Richard A. PaulsonPresident and CEO
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$1,680
236 sh
$1,680
Filed 25/05/07
Traded 25/05/06
Richard A. PaulsonPresident and CEO
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$916
245 sh
$916
Filed 25/04/07
Traded 25/04/04
Richard A. PaulsonPresident and CEO
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$73.6K
11,694 sh
$73.6K
Filed 25/03/06
Traded 25/03/04